Cargando…
Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design
BACKGROUND: Several studies have shown an association of cryptogenic stroke and embolism with patent foramen ovale (PFO), but the question how to prevent further events in such patients is unresolved. Options include antithrombotic treatment with warfarin or antiplatelet agents or surgical or endova...
Autores principales: | Khattab, Ahmed A, Windecker, Stephan, Jüni, Peter, Hildick-Smith, David, Dudek, Dariusz, Andersen, Henning R, Ibrahim, Reda, Schuler, Gerhard, Walton, Antony S, Wahl, Andreas, Mattle, Heinrich P, Meier, Bernhard |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058012/ https://www.ncbi.nlm.nih.gov/pubmed/21356042 http://dx.doi.org/10.1186/1745-6215-12-56 |
Ejemplares similares
-
Clinical Experience of Percutaneous Patent Foramen Ovale Closure Using the Amplatzer PFO Occluder in Japanese Patients to Prevent the Recurrence of Cryptogenic Stroke
por: Takafuji, Hiroya, et al.
Publicado: (2021) -
Multidisciplinary management of patent foramen ovale (PFO) and cryptogenic stroke/TIA
por: Mirzada, Naqibullah, et al.
Publicado: (2013) -
Patent foramen ovale occlusion with the Cocoon PFO Occluder. The PROS-IT collaborative project
por: Testa, Luca, et al.
Publicado: (2023) -
Managing Patent Foramen Ovale (PFO) in Adults With Cryptogenic Stroke and Lymphoma: A Multidisciplinary Perspective
por: Khalid, Noman, et al.
Publicado: (2023) -
Long-term follow-up after percutaneous closure of patent foramen ovale with Amplatzer PFO Occluder: a single center experience
por: Araszkiewicz, Aleksander, et al.
Publicado: (2016)